

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lens morphogenesis in camera-type eye (GO:0002089) | 8.25226557 |
| 2 | visual perception (GO:0007601) | 8.16632592 |
| 3 | sensory perception of light stimulus (GO:0050953) | 8.13969574 |
| 4 | response to muscle activity (GO:0014850) | 7.60175778 |
| 5 | protein refolding (GO:0042026) | 6.72821823 |
| 6 | camera-type eye development (GO:0043010) | 6.58672472 |
| 7 | histone H3-K9 demethylation (GO:0033169) | 6.21997152 |
| 8 | cytolysis (GO:0019835) | 6.19614247 |
| 9 | muscle cell cellular homeostasis (GO:0046716) | 6.14102557 |
| 10 | regulation of protein sumoylation (GO:0033233) | 6.08504064 |
| 11 | eye development (GO:0001654) | 5.76466213 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 5.76049252 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 5.76049252 |
| 14 | nodal signaling pathway (GO:0038092) | 5.43832282 |
| 15 | bile acid and bile salt transport (GO:0015721) | 5.19533589 |
| 16 | positive regulation of gluconeogenesis (GO:0045722) | 5.16504990 |
| 17 | negative regulation of execution phase of apoptosis (GO:1900118) | 5.00064531 |
| 18 | sensory organ development (GO:0007423) | 4.61637397 |
| 19 | myofibril assembly (GO:0030239) | 4.53315826 |
| 20 | cellular response to osmotic stress (GO:0071470) | 4.49847289 |
| 21 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 4.17001488 |
| 22 | COPII vesicle coating (GO:0048208) | 4.16256331 |
| 23 | auditory receptor cell differentiation (GO:0042491) | 4.10363328 |
| 24 | nephron epithelium morphogenesis (GO:0072088) | 4.04324310 |
| 25 | nephron tubule morphogenesis (GO:0072078) | 4.04324310 |
| 26 | sensory perception (GO:0007600) | 4.03408637 |
| 27 | inositol phosphate catabolic process (GO:0071545) | 4.01935621 |
| 28 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.99411847 |
| 29 | respiratory chain complex IV assembly (GO:0008535) | 3.98443248 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 3.95781052 |
| 31 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.93493164 |
| 32 | regulation of autophagic vacuole assembly (GO:2000785) | 3.93029735 |
| 33 | response to salt stress (GO:0009651) | 3.92803645 |
| 34 | inositol phosphate dephosphorylation (GO:0046855) | 3.90326651 |
| 35 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.90326651 |
| 36 | chemosensory behavior (GO:0007635) | 3.90125938 |
| 37 | negative regulation of JUN kinase activity (GO:0043508) | 3.85215050 |
| 38 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.84843598 |
| 39 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.83228048 |
| 40 | positive regulation of calcium ion import (GO:0090280) | 3.81382203 |
| 41 | energy homeostasis (GO:0097009) | 3.75856494 |
| 42 | cytochrome complex assembly (GO:0017004) | 3.74060292 |
| 43 | endocrine pancreas development (GO:0031018) | 3.70871720 |
| 44 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.68018154 |
| 45 | L-phenylalanine metabolic process (GO:0006558) | 3.66881778 |
| 46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.66881778 |
| 47 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.65910632 |
| 48 | response to nitrosative stress (GO:0051409) | 3.62468525 |
| 49 | peptide hormone processing (GO:0016486) | 3.61550602 |
| 50 | L-phenylalanine catabolic process (GO:0006559) | 3.57512936 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.57512936 |
| 52 | cellular response to vitamin D (GO:0071305) | 3.51741766 |
| 53 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.51280565 |
| 54 | protein retention in ER lumen (GO:0006621) | 3.49991473 |
| 55 | ketone body metabolic process (GO:1902224) | 3.47723363 |
| 56 | detection of calcium ion (GO:0005513) | 3.47028762 |
| 57 | sarcomere organization (GO:0045214) | 3.41880229 |
| 58 | renal tubule morphogenesis (GO:0061333) | 3.40598324 |
| 59 | regulation of vacuole organization (GO:0044088) | 3.39886455 |
| 60 | positive regulation of insulin secretion (GO:0032024) | 3.38475643 |
| 61 | regulation of extracellular matrix disassembly (GO:0010715) | 3.38130433 |
| 62 | glandular epithelial cell differentiation (GO:0002067) | 3.34217885 |
| 63 | somite rostral/caudal axis specification (GO:0032525) | 3.33904721 |
| 64 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.31512685 |
| 65 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.29521714 |
| 66 | positive regulation of glycolytic process (GO:0045821) | 3.27978957 |
| 67 | nitric oxide biosynthetic process (GO:0006809) | 3.27312515 |
| 68 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.21232971 |
| 69 | positive regulation of neurotransmitter transport (GO:0051590) | 3.20944048 |
| 70 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.20312813 |
| 71 | serotonin metabolic process (GO:0042428) | 3.17145654 |
| 72 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.14378266 |
| 73 | positive regulation of macroautophagy (GO:0016239) | 3.13657981 |
| 74 | brain morphogenesis (GO:0048854) | 3.13052728 |
| 75 | glycerophospholipid catabolic process (GO:0046475) | 3.10493244 |
| 76 | water transport (GO:0006833) | 3.10339718 |
| 77 | polyol catabolic process (GO:0046174) | 3.09913482 |
| 78 | cysteine metabolic process (GO:0006534) | 3.08176541 |
| 79 | regulation of neurotransmitter uptake (GO:0051580) | 3.06479590 |
| 80 | toxin metabolic process (GO:0009404) | 3.03750708 |
| 81 | type B pancreatic cell development (GO:0003323) | 3.01307216 |
| 82 | * lens development in camera-type eye (GO:0002088) | 27.6368088 |
| 83 | lens fiber cell development (GO:0070307) | 20.2754893 |
| 84 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.98658489 |
| 85 | positive regulation of response to nutrient levels (GO:0032109) | 2.98658489 |
| 86 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.97548261 |
| 87 | regulation of hexokinase activity (GO:1903299) | 2.97495230 |
| 88 | regulation of glucokinase activity (GO:0033131) | 2.97495230 |
| 89 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.96716137 |
| 90 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.96260594 |
| 91 | vesicle coating (GO:0006901) | 2.93069530 |
| 92 | insulin secretion (GO:0030073) | 2.91650885 |
| 93 | primary amino compound metabolic process (GO:1901160) | 2.90208509 |
| 94 | glutathione derivative biosynthetic process (GO:1901687) | 2.88348344 |
| 95 | glutathione derivative metabolic process (GO:1901685) | 2.88348344 |
| 96 | regulation of insulin secretion (GO:0050796) | 2.88069385 |
| 97 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.87183830 |
| 98 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.87183830 |
| 99 | toxin transport (GO:1901998) | 2.86851775 |
| 100 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.85447593 |
| 101 | cellular sodium ion homeostasis (GO:0006883) | 2.85148872 |
| 102 | inositol phosphate-mediated signaling (GO:0048016) | 2.85059025 |
| 103 | beta-amyloid metabolic process (GO:0050435) | 2.84859880 |
| 104 | retinol metabolic process (GO:0042572) | 2.84187172 |
| 105 | regulation of myoblast differentiation (GO:0045661) | 2.82838057 |
| 106 | dentate gyrus development (GO:0021542) | 2.82101817 |
| 107 | regulation of execution phase of apoptosis (GO:1900117) | 2.81573061 |
| 108 | xenobiotic catabolic process (GO:0042178) | 2.80553162 |
| 109 | organic cation transport (GO:0015695) | 2.79946215 |
| 110 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.79182243 |
| 111 | sequestering of metal ion (GO:0051238) | 2.78401616 |
| 112 | protein autoprocessing (GO:0016540) | 2.76014997 |
| 113 | axoneme assembly (GO:0035082) | 2.75864681 |
| 114 | signal peptide processing (GO:0006465) | 2.75842990 |
| 115 | dopaminergic neuron differentiation (GO:0071542) | 2.75487360 |
| 116 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.75199073 |
| 117 | C-terminal protein lipidation (GO:0006501) | 2.72782357 |
| 118 | positive regulation of peptide hormone secretion (GO:0090277) | 2.72396558 |
| 119 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.71315790 |
| 120 | zinc ion homeostasis (GO:0055069) | 2.69074403 |
| 121 | magnesium ion transport (GO:0015693) | 2.67877591 |
| 122 | regulation of platelet aggregation (GO:0090330) | 2.67842100 |
| 123 | peptide transport (GO:0015833) | 2.66677877 |
| 124 | snRNA transcription (GO:0009301) | 2.66671039 |
| 125 | regulation of oxidative phosphorylation (GO:0002082) | 2.66383686 |
| 126 | fluid transport (GO:0042044) | 2.64642062 |
| 127 | positive regulation of meiosis (GO:0045836) | 2.64490555 |
| 128 | response to dietary excess (GO:0002021) | 2.63993164 |
| 129 | positive regulation of peptide secretion (GO:0002793) | 2.63777814 |
| 130 | response to pheromone (GO:0019236) | 2.63540751 |
| 131 | regulation of peptide hormone secretion (GO:0090276) | 2.62613879 |
| 132 | protein homotrimerization (GO:0070207) | 2.62123567 |
| 133 | activin receptor signaling pathway (GO:0032924) | 2.60845177 |
| 134 | lactate metabolic process (GO:0006089) | 2.59588028 |
| 135 | regulation of peptide secretion (GO:0002791) | 2.57846189 |
| 136 | protein maturation by protein folding (GO:0022417) | 2.57586273 |
| 137 | macroautophagy (GO:0016236) | 2.53741722 |
| 138 | neuron fate specification (GO:0048665) | 2.51011047 |
| 139 | positive regulation of vesicle fusion (GO:0031340) | 2.47887841 |
| 140 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.44065520 |
| 141 | lung epithelium development (GO:0060428) | 2.42727557 |
| 142 | positive regulation of calcium ion transport into cytosol (GO:0010524) | 2.41350340 |
| 143 | negative regulation of insulin secretion (GO:0046676) | 2.39330960 |
| 144 | dorsal/ventral axis specification (GO:0009950) | 2.32923187 |
| 145 | negative regulation of catecholamine secretion (GO:0033604) | 2.32606471 |
| 146 | cellular response to vitamin (GO:0071295) | 2.31274791 |
| 147 | peptide hormone secretion (GO:0030072) | 2.30970416 |
| 148 | exocrine pancreas development (GO:0031017) | 2.30337318 |
| 149 | regulation of hormone secretion (GO:0046883) | 2.29679171 |
| 150 | regulation of Rac protein signal transduction (GO:0035020) | 2.28755446 |
| 151 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.28482052 |
| 152 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.28114043 |
| 153 | negative regulation of cell size (GO:0045792) | 2.27360569 |
| 154 | positive regulation of nuclease activity (GO:0032075) | 2.26772855 |
| 155 | cellular response to glucagon stimulus (GO:0071377) | 2.24881724 |
| 156 | astrocyte differentiation (GO:0048708) | 2.22109242 |
| 157 | peptide secretion (GO:0002790) | 2.21688324 |
| 158 | glycine transport (GO:0015816) | 2.21426624 |
| 159 | cellular response to prostaglandin stimulus (GO:0071379) | 2.19946926 |
| 160 | negative regulation of norepinephrine secretion (GO:0010700) | 2.19637726 |
| 161 | response to activity (GO:0014823) | 2.19044590 |
| 162 | nitric oxide mediated signal transduction (GO:0007263) | 2.18070284 |
| 163 | intermediate filament cytoskeleton organization (GO:0045104) | 2.17767674 |
| 164 | histone lysine demethylation (GO:0070076) | 2.15979764 |
| 165 | cellular response to calcium ion (GO:0071277) | 2.15025784 |
| 166 | epithelial cell fate commitment (GO:0072148) | 2.15011518 |
| 167 | regulation of skeletal muscle fiber development (GO:0048742) | 2.14642136 |
| 168 | positive regulation of hormone secretion (GO:0046887) | 2.14485356 |
| 169 | cornea development in camera-type eye (GO:0061303) | 2.14400367 |
| 170 | negative regulation of osteoblast proliferation (GO:0033689) | 2.13792208 |
| 171 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.13081848 |
| 172 | intermediate filament-based process (GO:0045103) | 2.11975113 |
| 173 | epithelial cell development (GO:0002064) | 2.11491632 |
| 174 | lens fiber cell differentiation (GO:0070306) | 16.5105503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 9.53406168 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 4.66117875 |
| 3 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 4.60059612 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.30611955 |
| 5 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.87707724 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65866142 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.53820548 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.42338995 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.34324398 |
| 10 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23147223 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.22419492 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.16481104 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.13064606 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.09789291 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.04128028 |
| 16 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.87023164 |
| 17 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.81217608 |
| 18 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.80297627 |
| 19 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.80187012 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.79244650 |
| 21 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.79050973 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75068084 |
| 23 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.74141829 |
| 24 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.73528739 |
| 25 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.65019774 |
| 26 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64065870 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63232352 |
| 28 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62418036 |
| 29 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.62149190 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.61372462 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57680922 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55283342 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54853757 |
| 34 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.51936404 |
| 35 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.50742779 |
| 36 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.50148038 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48566084 |
| 38 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.47730715 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46557121 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45673148 |
| 41 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.43091238 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42467969 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41682919 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40753072 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40608190 |
| 46 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.40139200 |
| 47 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.39884900 |
| 48 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.39638978 |
| 49 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.39172125 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37822207 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37186514 |
| 52 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.36944118 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35879172 |
| 54 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.35149964 |
| 55 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.34377407 |
| 56 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.33687940 |
| 57 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32857629 |
| 58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32674651 |
| 59 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32207152 |
| 60 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.31194702 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31150040 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31150040 |
| 63 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.30503350 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29980287 |
| 65 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.28923478 |
| 66 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.27325313 |
| 67 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26622134 |
| 68 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.26234536 |
| 69 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25646339 |
| 70 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24696642 |
| 71 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.23555634 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23220964 |
| 73 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.22877651 |
| 74 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22855112 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21997003 |
| 76 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.21639915 |
| 77 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.20811920 |
| 78 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.20716082 |
| 79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20467578 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20078575 |
| 81 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.20031499 |
| 82 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19891440 |
| 83 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18570787 |
| 84 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18284686 |
| 85 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17456442 |
| 86 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17355428 |
| 87 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.16753760 |
| 88 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.16753760 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 1.16691915 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15589346 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15443649 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14407343 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14407343 |
| 94 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12694719 |
| 95 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12492146 |
| 96 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.12229355 |
| 97 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11907256 |
| 98 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.11893788 |
| 99 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.11281477 |
| 100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09195243 |
| 101 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.08613275 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08533407 |
| 103 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.07781044 |
| 104 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07285051 |
| 105 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.06148685 |
| 106 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.06148685 |
| 107 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06055293 |
| 108 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04849453 |
| 109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04442275 |
| 110 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04341871 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02166124 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02105358 |
| 113 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.01295350 |
| 114 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00807313 |
| 115 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00259890 |
| 116 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99337705 |
| 117 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98256582 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97683851 |
| 119 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97239099 |
| 120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96334362 |
| 121 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95915825 |
| 122 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95800765 |
| 123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95659743 |
| 124 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.95040598 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94486874 |
| 126 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94095298 |
| 127 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93934240 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92984234 |
| 129 | EWS_26573619_Chip-Seq_HEK293_Human | 0.92075330 |
| 130 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92036089 |
| 131 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.91937777 |
| 132 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.91789927 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90692633 |
| 134 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90386402 |
| 135 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.89479597 |
| 136 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89306859 |
| 137 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86017010 |
| 138 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.85877411 |
| 139 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.85086935 |
| 140 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84793499 |
| 141 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.84770469 |
| 142 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.82908477 |
| 143 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82567641 |
| 144 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.82295261 |
| 145 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.82024144 |
| 146 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.80844006 |
| 147 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80511556 |
| 148 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79436664 |
| 149 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.79070625 |
| 150 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.78758584 |
| 151 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78514765 |
| 152 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.78218849 |
| 153 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77415586 |
| 154 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77312055 |
| 155 | TCF4_23295773_ChIP-Seq_U87_Human | 0.77153899 |
| 156 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.74731235 |
| 157 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.74373353 |
| 158 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.74277090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005193_abnormal_anterior_eye | 7.31690097 |
| 2 | MP0005253_abnormal_eye_physiology | 4.98996192 |
| 3 | MP0003941_abnormal_skin_development | 3.73311993 |
| 4 | MP0001286_abnormal_eye_development | 3.02567864 |
| 5 | MP0005391_vision/eye_phenotype | 2.88186343 |
| 6 | MP0000749_muscle_degeneration | 2.86137901 |
| 7 | MP0002092_abnormal_eye_morphology | 2.80958306 |
| 8 | MP0005197_abnormal_uvea_morphology | 2.74754495 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.73248899 |
| 10 | MP0002638_abnormal_pupillary_reflex | 2.50851625 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.46016733 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.30350577 |
| 13 | MP0002090_abnormal_vision | 2.11118176 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.05224195 |
| 15 | MP0002697_abnormal_eye_size | 11.8445349 |
| 16 | MP0005379_endocrine/exocrine_gland_phen | 1.93634127 |
| 17 | MP0002254_reproductive_system_inflammat | 1.89839961 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 1.88978602 |
| 19 | MP0003195_calcinosis | 1.87007703 |
| 20 | MP0005332_abnormal_amino_acid | 1.83503492 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.80877914 |
| 22 | MP0002909_abnormal_adrenal_gland | 1.79062215 |
| 23 | MP0006072_abnormal_retinal_apoptosis | 1.70676274 |
| 24 | MP0001944_abnormal_pancreas_morphology | 1.66692270 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.65820240 |
| 26 | MP0003122_maternal_imprinting | 1.64444784 |
| 27 | MP0009046_muscle_twitch | 1.63269521 |
| 28 | MP0004043_abnormal_pH_regulation | 1.58347984 |
| 29 | MP0003787_abnormal_imprinting | 1.50728392 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.47772146 |
| 31 | MP0005365_abnormal_bile_salt | 1.47692454 |
| 32 | MP0002822_catalepsy | 1.47024546 |
| 33 | MP0002693_abnormal_pancreas_physiology | 1.45787900 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.45274638 |
| 35 | MP0000678_abnormal_parathyroid_gland | 1.44731055 |
| 36 | MP0001346_abnormal_lacrimal_gland | 1.44722303 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.42955018 |
| 38 | MP0004133_heterotaxia | 1.40243234 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.39279929 |
| 40 | MP0002108_abnormal_muscle_morphology | 1.34045931 |
| 41 | MP0002163_abnormal_gland_morphology | 1.33820383 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.29684941 |
| 43 | MP0006292_abnormal_olfactory_placode | 1.26085150 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.25541001 |
| 45 | MP0000427_abnormal_hair_cycle | 1.24224149 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.24080401 |
| 47 | MP0009745_abnormal_behavioral_response | 1.22826092 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.22212041 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.20355284 |
| 50 | MP0003283_abnormal_digestive_organ | 1.18993982 |
| 51 | MP0001299_abnormal_eye_distance/ | 1.18776468 |
| 52 | MP0002269_muscular_atrophy | 1.18552175 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.16524819 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.15112603 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.13977360 |
| 56 | MP0004924_abnormal_behavior | 1.13977360 |
| 57 | MP0002009_preneoplasia | 1.13421127 |
| 58 | MP0003123_paternal_imprinting | 1.10894874 |
| 59 | MP0005248_abnormal_Harderian_gland | 1.10403495 |
| 60 | MP0003186_abnormal_redox_activity | 1.08319748 |
| 61 | MP0003011_delayed_dark_adaptation | 1.05471046 |
| 62 | MP0005195_abnormal_posterior_eye | 1.05204010 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.03384301 |
| 64 | MP0003959_abnormal_lean_body | 1.03198254 |
| 65 | MP0003137_abnormal_impulse_conducting | 1.03126353 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.01976786 |
| 67 | MP0009384_cardiac_valve_regurgitation | 1.00104547 |
| 68 | MP0003633_abnormal_nervous_system | 0.99842874 |
| 69 | MP0000639_abnormal_adrenal_gland | 0.97194450 |
| 70 | MP0004270_analgesia | 0.97192817 |
| 71 | MP0002734_abnormal_mechanical_nocicepti | 0.96904677 |
| 72 | MP0002733_abnormal_thermal_nociception | 0.94057062 |
| 73 | MP0001765_abnormal_ion_homeostasis | 0.93319681 |
| 74 | MP0001529_abnormal_vocalization | 0.91998858 |
| 75 | MP0004272_abnormal_basement_membrane | 0.91913310 |
| 76 | MP0004215_abnormal_myocardial_fiber | 0.90726750 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 0.89654082 |
| 78 | MP0002064_seizures | 0.89275526 |
| 79 | MP0002938_white_spotting | 0.88455876 |
| 80 | MP0000566_synostosis | 0.88106208 |
| 81 | MP0005330_cardiomyopathy | 0.86751133 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.86469266 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.86248637 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.84262556 |
| 85 | MP0002063_abnormal_learning/memory/cond | 0.82011926 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 0.79273618 |
| 87 | MP0010368_abnormal_lymphatic_system | 0.78540984 |
| 88 | MP0004147_increased_porphyrin_level | 0.78367833 |
| 89 | MP0002653_abnormal_ependyma_morphology | 0.74191158 |
| 90 | MP0002177_abnormal_outer_ear | 0.73548587 |
| 91 | MP0004085_abnormal_heartbeat | 0.72971623 |
| 92 | MP0001666_abnormal_nutrient_absorption | 0.72923959 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.72889936 |
| 94 | MP0002069_abnormal_eating/drinking_beha | 0.72762782 |
| 95 | MP0008872_abnormal_physiological_respon | 0.69851282 |
| 96 | MP0005452_abnormal_adipose_tissue | 0.69209200 |
| 97 | MP0000470_abnormal_stomach_morphology | 0.68412762 |
| 98 | MP0000049_abnormal_middle_ear | 0.67843117 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.66890920 |
| 100 | MP0003786_premature_aging | 0.66693461 |
| 101 | MP0005535_abnormal_body_temperature | 0.66578852 |
| 102 | MP0003121_genomic_imprinting | 0.65707509 |
| 103 | MP0004233_abnormal_muscle_weight | 0.65088070 |
| 104 | MP0002751_abnormal_autonomic_nervous | 0.64633551 |
| 105 | MP0005646_abnormal_pituitary_gland | 0.63023577 |
| 106 | MP0002166_altered_tumor_susceptibility | 0.62885751 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.62719837 |
| 108 | MP0003119_abnormal_digestive_system | 0.61240175 |
| 109 | MP0003252_abnormal_bile_duct | 0.59448323 |
| 110 | MP0002184_abnormal_innervation | 0.59140841 |
| 111 | MP0002928_abnormal_bile_duct | 0.57692456 |
| 112 | MP0005187_abnormal_penis_morphology | 0.57557300 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.57444760 |
| 114 | MP0001905_abnormal_dopamine_level | 0.56828825 |
| 115 | MP0001324_abnormal_eye_pigmentation | 0.56425457 |
| 116 | MP0001340_abnormal_eyelid_morphology | 0.56329639 |
| 117 | MP0006276_abnormal_autonomic_nervous | 0.55619921 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.54653489 |
| 119 | MP0002272_abnormal_nervous_system | 0.50856598 |
| 120 | MP0003953_abnormal_hormone_level | 0.50457113 |
| 121 | MP0001970_abnormal_pain_threshold | 0.50195336 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.49137769 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.48856340 |
| 124 | MP0001188_hyperpigmentation | 0.48460591 |
| 125 | MP0002557_abnormal_social/conspecific_i | 0.48194567 |
| 126 | MP0003879_abnormal_hair_cell | 0.47785167 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.46863996 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.46572091 |
| 129 | MP0005369_muscle_phenotype | 0.46097233 |
| 130 | MP0003635_abnormal_synaptic_transmissio | 0.46044485 |
| 131 | MP0002572_abnormal_emotion/affect_behav | 0.45404331 |
| 132 | MP0000955_abnormal_spinal_cord | 0.44799143 |
| 133 | MP0004885_abnormal_endolymph | 0.44433199 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.42786568 |
| 135 | MP0008961_abnormal_basal_metabolism | 0.41723963 |
| 136 | MP0001661_extended_life_span | 0.40815235 |
| 137 | MP0005448_abnormal_energy_balance | 0.40319925 |
| 138 | MP0001756_abnormal_urination | 0.39681030 |
| 139 | MP0001968_abnormal_touch/_nociception | 0.39552391 |
| 140 | MP0000631_abnormal_neuroendocrine_gland | 0.39284727 |
| 141 | MP0009643_abnormal_urine_homeostasis | 0.37342632 |
| 142 | MP0002896_abnormal_bone_mineralization | 0.37193449 |
| 143 | MP0002229_neurodegeneration | 0.36692715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Corneal dystrophy (HP:0001131) | 6.91237636 |
| 2 | * Congenital cataract (HP:0000519) | 6.82640438 |
| 3 | Congenital malformation of the right heart (HP:0011723) | 6.63224072 |
| 4 | Double outlet right ventricle (HP:0001719) | 6.63224072 |
| 5 | Amblyopia (HP:0000646) | 6.58758312 |
| 6 | Increased circulating renin level (HP:0000848) | 6.20797417 |
| 7 | Anterior segment dysgenesis (HP:0007700) | 5.54508333 |
| 8 | Hyperkalemia (HP:0002153) | 4.77881097 |
| 9 | Hyperactive renin-angiotensin system (HP:0000841) | 4.36734804 |
| 10 | Polar cataract (HP:0010696) | 4.11941637 |
| 11 | Microcornea (HP:0000482) | 3.63756895 |
| 12 | Clumsiness (HP:0002312) | 3.56328265 |
| 13 | Hematochezia (HP:0002573) | 3.19507223 |
| 14 | Hypoalbuminemia (HP:0003073) | 3.11983229 |
| 15 | Abnormal albumin level (HP:0012116) | 3.11983229 |
| 16 | Nuclear cataract (HP:0100018) | 26.2667849 |
| 17 | Zonular cataract (HP:0010920) | 23.6841396 |
| 18 | Abnormality of renin-angiotensin system (HP:0000847) | 2.98850352 |
| 19 | Abnormality of vitamin B metabolism (HP:0004340) | 2.91863472 |
| 20 | Iris coloboma (HP:0000612) | 2.91270683 |
| 21 | Abnormality of potassium homeostasis (HP:0011042) | 2.84414581 |
| 22 | Hyperaldosteronism (HP:0000859) | 2.74609540 |
| 23 | Increased CSF protein (HP:0002922) | 2.70786252 |
| 24 | Opacification of the corneal stroma (HP:0007759) | 2.64062392 |
| 25 | Congenital primary aphakia (HP:0007707) | 2.57955653 |
| 26 | Ketosis (HP:0001946) | 2.53875194 |
| 27 | Eosinophilia (HP:0001880) | 2.53264023 |
| 28 | Abnormality of abdominal situs (HP:0011620) | 2.53259757 |
| 29 | Abdominal situs inversus (HP:0003363) | 2.53259757 |
| 30 | Enlarged penis (HP:0000040) | 2.50633992 |
| 31 | Toxemia of pregnancy (HP:0100603) | 2.49881468 |
| 32 | Abnormality of vitamin metabolism (HP:0100508) | 2.41459525 |
| 33 | Vascular calcification (HP:0004934) | 2.38359319 |
| 34 | Mesangial abnormality (HP:0001966) | 2.37736823 |
| 35 | Sclerocornea (HP:0000647) | 2.34539663 |
| 36 | Hemiparesis (HP:0001269) | 2.32383925 |
| 37 | Gastrointestinal atresia (HP:0002589) | 2.31354053 |
| 38 | Ventricular fibrillation (HP:0001663) | 2.27543172 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.27323315 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.27323315 |
| 41 | Postural tremor (HP:0002174) | 2.25085809 |
| 42 | Progressive neurologic deterioration (HP:0002344) | 2.24789124 |
| 43 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.23363842 |
| 44 | Proximal tubulopathy (HP:0000114) | 2.21567822 |
| 45 | Abnormality of the anterior chamber (HP:0000593) | 2.18545457 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.18400381 |
| 47 | Hyponatremia (HP:0002902) | 2.17308086 |
| 48 | Congenital sensorineural hearing impairment (HP:0008527) | 2.15679040 |
| 49 | Abnormal sex determination (HP:0012244) | 2.14177170 |
| 50 | Sex reversal (HP:0012245) | 2.14177170 |
| 51 | Popliteal pterygium (HP:0009756) | 2.14004960 |
| 52 | Oligodactyly (hands) (HP:0001180) | 2.13558231 |
| 53 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.12261712 |
| 54 | Aqueductal stenosis (HP:0002410) | 2.12209728 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12129664 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12129664 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12129664 |
| 58 | Truncus arteriosus (HP:0001660) | 2.09497627 |
| 59 | Abnormality of chloride homeostasis (HP:0011422) | 2.09230999 |
| 60 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.08963275 |
| 61 | Unilateral renal agenesis (HP:0000122) | 2.07790506 |
| 62 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.07399129 |
| 63 | Methylmalonic acidemia (HP:0002912) | 2.03640557 |
| 64 | Testicular atrophy (HP:0000029) | 2.03319561 |
| 65 | Posterior subcapsular cataract (HP:0007787) | 2.02470335 |
| 66 | Muscular hypotonia of the trunk (HP:0008936) | 2.02119090 |
| 67 | Granulocytopenia (HP:0001913) | 2.02012079 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.01111578 |
| 69 | Conjunctival hamartoma (HP:0100780) | 2.00312928 |
| 70 | Renal cortical cysts (HP:0000803) | 1.98637187 |
| 71 | Syncope (HP:0001279) | 1.97911399 |
| 72 | Glycosuria (HP:0003076) | 1.97215592 |
| 73 | Abnormality of urine glucose concentration (HP:0011016) | 1.97215592 |
| 74 | Abnormal biliary tract morphology (HP:0012440) | 1.97166635 |
| 75 | Anxiety (HP:0000739) | 1.96629811 |
| 76 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.95698277 |
| 77 | J-shaped sella turcica (HP:0002680) | 1.95532310 |
| 78 | Proximal amyotrophy (HP:0007126) | 1.95055817 |
| 79 | Hypokinesia (HP:0002375) | 1.94754628 |
| 80 | Mucopolysacchariduria (HP:0008155) | 1.94487094 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94487094 |
| 82 | Abnormality of the renal cortex (HP:0011035) | 1.90252061 |
| 83 | Neuroendocrine neoplasm (HP:0100634) | 1.90061479 |
| 84 | Testicular neoplasm (HP:0010788) | 1.89657615 |
| 85 | Hypoglycemic seizures (HP:0002173) | 1.87077470 |
| 86 | Orthostatic hypotension (HP:0001278) | 1.86303442 |
| 87 | Abnormality of renal resorption (HP:0011038) | 1.85463837 |
| 88 | Glucose intolerance (HP:0000833) | 1.83456878 |
| 89 | Progressive macrocephaly (HP:0004481) | 1.82923066 |
| 90 | Palpitations (HP:0001962) | 1.82507918 |
| 91 | Adrenal overactivity (HP:0002717) | 1.79833974 |
| 92 | Gaze-evoked nystagmus (HP:0000640) | 1.78953638 |
| 93 | Scapular winging (HP:0003691) | 1.77022471 |
| 94 | Poor suck (HP:0002033) | 1.76974942 |
| 95 | Hypoglycemic coma (HP:0001325) | 1.71989430 |
| 96 | Symptomatic seizures (HP:0011145) | 1.66826270 |
| 97 | Abnormality of eosinophils (HP:0001879) | 1.64921721 |
| 98 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.55770126 |
| 99 | Abnormality of the labia majora (HP:0012881) | 1.53650775 |
| 100 | Fetal akinesia sequence (HP:0001989) | 1.40160776 |
| 101 | Neonatal respiratory distress (HP:0002643) | 1.39072273 |
| 102 | Akinesia (HP:0002304) | 1.37631814 |
| 103 | Hyperglycemia (HP:0003074) | 1.32153244 |
| 104 | Aplasia of the musculature (HP:0100854) | 1.28452402 |
| 105 | Abnormal pancreas size (HP:0012094) | 1.27453284 |
| 106 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.24731180 |
| 107 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.24731180 |
| 108 | Difficulty walking (HP:0002355) | 1.24139089 |
| 109 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.23416363 |
| 110 | Late onset (HP:0003584) | 1.14851694 |
| 111 | Large for gestational age (HP:0001520) | 1.14490329 |
| 112 | Agitation (HP:0000713) | 1.14008713 |
| 113 | Hyperparathyroidism (HP:0000843) | 1.10462246 |
| 114 | Ketoacidosis (HP:0001993) | 1.10254860 |
| 115 | Neoplasm of the heart (HP:0100544) | 1.09707147 |
| 116 | Hypoplastic nipples (HP:0002557) | 1.09679475 |
| 117 | Long clavicles (HP:0000890) | 1.09508280 |
| 118 | Rib fusion (HP:0000902) | 1.07288671 |
| 119 | Severe visual impairment (HP:0001141) | 1.03093616 |
| 120 | Amniotic constriction ring (HP:0009775) | 1.02824670 |
| 121 | Abnormality of placental membranes (HP:0011409) | 1.02824670 |
| 122 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.02663251 |
| 123 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 0.97657164 |
| 124 | Abnormality of the shoulder girdle musculature (HP:0001435) | 0.97330330 |
| 125 | Hypoplasia of the fovea (HP:0007750) | 0.96714722 |
| 126 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 0.96714722 |
| 127 | Atelectasis (HP:0100750) | 0.96256299 |
| 128 | Hyperphosphatemia (HP:0002905) | 0.94757800 |
| 129 | Decreased circulating renin level (HP:0003351) | 0.94220036 |
| 130 | Vertebral clefting (HP:0008428) | 0.93348274 |
| 131 | Retinal atrophy (HP:0001105) | 0.93278696 |
| 132 | Hypothermia (HP:0002045) | 0.93104304 |
| 133 | Leukocytosis (HP:0001974) | 0.92294782 |
| 134 | Subcapsular cataract (HP:0000523) | 0.90871790 |
| 135 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 0.89072878 |
| 136 | Limb hypertonia (HP:0002509) | 0.88377612 |
| 137 | Chorioretinal coloboma (HP:0000567) | 0.87447059 |
| 138 | Fused cervical vertebrae (HP:0002949) | 0.86686255 |
| 139 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 0.85835977 |
| 140 | Intestinal atresia (HP:0011100) | 0.85464992 |
| 141 | Hepatoblastoma (HP:0002884) | 0.84229599 |
| 142 | Enlarged kidneys (HP:0000105) | 0.83817907 |
| 143 | Abnormality of the fovea (HP:0000493) | 0.83659104 |
| 144 | Abnormal rod and cone electroretinograms (HP:0008323) | 0.83520194 |
| 145 | Insulin-resistant diabetes mellitus (HP:0000831) | 0.83069530 |
| 146 | Congenital glaucoma (HP:0001087) | 0.80512038 |
| 147 | Skin nodule (HP:0200036) | 0.79471512 |
| 148 | Hyperthyroidism (HP:0000836) | 0.78513060 |
| 149 | Exostoses (HP:0100777) | 0.76486502 |
| 150 | Pterygium (HP:0001059) | 0.76166927 |
| 151 | Hypokalemia (HP:0002900) | 0.75112288 |
| 152 | Abnormality of the labia (HP:0000058) | 0.73708516 |
| 153 | Broad nasal tip (HP:0000455) | 0.73303352 |
| 154 | Menstrual irregularities (HP:0000858) | 0.72924066 |
| 155 | EEG with generalized epileptiform discharges (HP:0011198) | 0.72323991 |
| 156 | Restlessness (HP:0000711) | 0.71746758 |
| 157 | Osteomalacia (HP:0002749) | 0.71608032 |
| 158 | Hypsarrhythmia (HP:0002521) | 0.71456163 |
| 159 | Pheochromocytoma (HP:0002666) | 0.71424587 |
| 160 | Epileptiform EEG discharges (HP:0011182) | 0.69747322 |
| 161 | Dysautonomia (HP:0002459) | 0.69516826 |
| 162 | Macroorchidism (HP:0000053) | 0.69261926 |
| 163 | Generalized aminoaciduria (HP:0002909) | 0.68673073 |
| 164 | Hypoplasia of the uterus (HP:0000013) | 0.68566863 |
| 165 | Hypotension (HP:0002615) | 0.67396123 |
| 166 | Prominent metopic ridge (HP:0005487) | 0.65913020 |
| 167 | Hypercortisolism (HP:0001578) | 0.65673155 |
| 168 | Thin ribs (HP:0000883) | 0.64740853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.72256058 |
| 2 | MAP2K6 | 5.33375195 |
| 3 | WNK3 | 5.01015586 |
| 4 | WNK4 | 4.61871585 |
| 5 | INSRR | 4.35549635 |
| 6 | PHKG1 | 3.08415810 |
| 7 | PHKG2 | 3.08415810 |
| 8 | FLT3 | 3.01324754 |
| 9 | NTRK1 | 2.65379795 |
| 10 | PIK3CG | 2.44504697 |
| 11 | NLK | 2.34874568 |
| 12 | GRK1 | 2.34320827 |
| 13 | BLK | 2.31237633 |
| 14 | IRAK4 | 2.12293142 |
| 15 | ADRBK2 | 2.11973002 |
| 16 | FGFR2 | 2.04633152 |
| 17 | HIPK2 | 1.98899325 |
| 18 | PRKG1 | 1.97383807 |
| 19 | PASK | 1.96423316 |
| 20 | SIK1 | 1.73001494 |
| 21 | TNIK | 1.72471183 |
| 22 | MAP3K9 | 1.70744832 |
| 23 | MAP4K2 | 1.67077805 |
| 24 | * SGK1 | 1.64968020 |
| 25 | UHMK1 | 1.63656840 |
| 26 | WNK1 | 1.63239488 |
| 27 | TRPM7 | 1.62714718 |
| 28 | FGFR3 | 1.51078626 |
| 29 | NTRK3 | 1.46939966 |
| 30 | MET | 1.45762024 |
| 31 | TAOK1 | 1.40274061 |
| 32 | STK39 | 1.38770284 |
| 33 | MKNK2 | 1.38137257 |
| 34 | STK3 | 1.35426372 |
| 35 | PRKD3 | 1.33658917 |
| 36 | IRAK1 | 1.27946028 |
| 37 | MST4 | 1.27703030 |
| 38 | AKT3 | 1.27529351 |
| 39 | PDGFRA | 1.24276337 |
| 40 | ERN1 | 1.23638354 |
| 41 | PLK2 | 1.23078591 |
| 42 | CSNK1G1 | 1.22963687 |
| 43 | IGF1R | 1.22193540 |
| 44 | MAP3K2 | 1.21029927 |
| 45 | PTK2 | 1.15050021 |
| 46 | PAK3 | 1.13634250 |
| 47 | PTK6 | 1.09253930 |
| 48 | EPHA2 | 1.07293537 |
| 49 | SCYL2 | 1.06705436 |
| 50 | MAPK10 | 1.05273211 |
| 51 | MAP3K12 | 1.05130627 |
| 52 | INSR | 1.03462807 |
| 53 | CSNK1G3 | 0.99975857 |
| 54 | STK38L | 0.96634283 |
| 55 | BRAF | 0.95588621 |
| 56 | BCKDK | 0.93819664 |
| 57 | TAOK3 | 0.92710532 |
| 58 | ZAP70 | 0.90575218 |
| 59 | TRIB3 | 0.89343141 |
| 60 | IRAK2 | 0.88419891 |
| 61 | CSNK1G2 | 0.83348668 |
| 62 | FRK | 0.82793180 |
| 63 | BMPR2 | 0.81803396 |
| 64 | SGK494 | 0.79881166 |
| 65 | SGK223 | 0.79881166 |
| 66 | EPHA3 | 0.78303362 |
| 67 | ACVR1B | 0.77604427 |
| 68 | DYRK1B | 0.77175605 |
| 69 | * PRKCB | 0.76555814 |
| 70 | STK11 | 0.76121519 |
| 71 | CAMKK2 | 0.75550556 |
| 72 | TNK2 | 0.74532784 |
| 73 | OXSR1 | 0.73048508 |
| 74 | PTK2B | 0.70598548 |
| 75 | ERBB2 | 0.70266395 |
| 76 | BMPR1B | 0.69839587 |
| 77 | PINK1 | 0.69017912 |
| 78 | PRKCI | 0.68826725 |
| 79 | PNCK | 0.66511379 |
| 80 | FER | 0.65841141 |
| 81 | CASK | 0.64539444 |
| 82 | BRD4 | 0.64021527 |
| 83 | PRKACG | 0.61761029 |
| 84 | CSNK1A1L | 0.61732996 |
| 85 | JAK1 | 0.60093505 |
| 86 | PRKACB | 0.59404012 |
| 87 | PRKAA1 | 0.58564708 |
| 88 | CDC42BPA | 0.58368128 |
| 89 | PRKCE | 0.57826084 |
| 90 | MAP2K2 | 0.55562715 |
| 91 | RPS6KA2 | 0.55240750 |
| 92 | ROCK2 | 0.54339049 |
| 93 | CAMK1G | 0.53702726 |
| 94 | PRKG2 | 0.53133498 |
| 95 | STK4 | 0.48384048 |
| 96 | DAPK1 | 0.47217724 |
| 97 | * RPS6KA3 | 0.46914995 |
| 98 | MAP3K1 | 0.46902070 |
| 99 | PRKCH | 0.46856722 |
| 100 | STK24 | 0.45764201 |
| 101 | CAMKK1 | 0.44352238 |
| 102 | ADRBK1 | 0.43767864 |
| 103 | ZAK | 0.43052432 |
| 104 | CSNK1D | 0.42813730 |
| 105 | YES1 | 0.41250513 |
| 106 | PRKAA2 | 0.40994061 |
| 107 | CDK5 | 0.38913442 |
| 108 | CAMK2A | 0.38412775 |
| 109 | PAK6 | 0.36953709 |
| 110 | DYRK2 | 0.35754996 |
| 111 | PRKCQ | 0.35678775 |
| 112 | CHUK | 0.35588263 |
| 113 | ERBB3 | 0.34620358 |
| 114 | PRKD2 | 0.34483677 |
| 115 | MAPK13 | 0.34473218 |
| 116 | STK38 | 0.34362645 |
| 117 | MAP2K7 | 0.33938564 |
| 118 | DYRK1A | 0.33536593 |
| 119 | MAP3K10 | 0.33322743 |
| 120 | MAP2K4 | 0.32879635 |
| 121 | JAK3 | 0.32578162 |
| 122 | AKT2 | 0.32117150 |
| 123 | PRKACA | 0.31449785 |
| 124 | MAP3K4 | 0.31077786 |
| 125 | RPS6KB1 | 0.30564859 |
| 126 | PRKCA | 0.29516571 |
| 127 | MINK1 | 0.29368494 |
| 128 | EPHB2 | 0.29063263 |
| 129 | PKN1 | 0.27502209 |
| 130 | PRKCG | 0.27473375 |
| 131 | MAPKAPK3 | 0.27047050 |
| 132 | CSNK2A2 | 0.26742744 |
| 133 | PKN2 | 0.26420548 |
| 134 | MYLK | 0.25947841 |
| 135 | ITK | 0.25941867 |
| 136 | MAP2K1 | 0.25597371 |
| 137 | LMTK2 | 0.25345939 |
| 138 | CAMK2D | 0.24979796 |
| 139 | CSNK1E | 0.24195972 |
| 140 | PRKCZ | 0.24185763 |
| 141 | NTRK2 | 0.23938525 |
| 142 | EIF2AK3 | 0.23615703 |
| 143 | LIMK1 | 0.21782887 |
| 144 | MAPKAPK2 | 0.21513239 |
| 145 | RPS6KA1 | 0.19723615 |
| 146 | CSK | 0.19449069 |
| 147 | TESK1 | 0.19156997 |
| 148 | ALK | 0.18955280 |
| 149 | MARK3 | 0.18763873 |
| 150 | CSNK1A1 | 0.18198549 |
| 151 | DAPK2 | 0.18114828 |
| 152 | SRPK1 | 0.17469928 |
| 153 | EGFR | 0.17467602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.52639102 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.57893724 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.64422238 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 3.37150149 |
| 5 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.48713499 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.14026251 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.05484801 |
| 8 | Cocaine addiction_Homo sapiens_hsa05030 | 2.01593282 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.00796512 |
| 10 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.96274388 |
| 11 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.93719529 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.87837822 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71141631 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69622672 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.69139737 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.64158871 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.61610369 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55692573 |
| 19 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.55689111 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.54642581 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.48971085 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.47392776 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.45066149 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.44900722 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.41547193 |
| 26 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.38478386 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37025020 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.34928061 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32029414 |
| 30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30350146 |
| 31 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.26704982 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26406467 |
| 33 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.22830378 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.21408570 |
| 35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.18369555 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.08848413 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06765269 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05801785 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03459352 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99315478 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97935898 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97463732 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96843802 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93667237 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 0.91011332 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 0.90614900 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88856574 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87445562 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86722009 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86409406 |
| 51 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86007627 |
| 52 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85887616 |
| 53 | Morphine addiction_Homo sapiens_hsa05032 | 0.85401952 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85037334 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.83158589 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82410846 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81487737 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.81263510 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.80590930 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77959339 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77388684 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75728514 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75546508 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75101860 |
| 65 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.74239072 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74184551 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72069001 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71919752 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71688365 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71498896 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70527648 |
| 72 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69326873 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.68915156 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68876142 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.66933013 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.66451907 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65973154 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.65674363 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64894391 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64227689 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63943748 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63616714 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63479100 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.63193407 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62634447 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61924136 |
| 87 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60850057 |
| 88 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.59263429 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57656801 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.57215315 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.57116208 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55600688 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55354486 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54571624 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53974992 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52807303 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51609204 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.51518244 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50753204 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50747260 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50478866 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50051545 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49733630 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49424798 |
| 105 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49149581 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49094807 |
| 107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49073899 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48433038 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48355418 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.45292228 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44273770 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43609208 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43395308 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.43261723 |
| 115 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43225729 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42934163 |
| 117 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42841095 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42014863 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41644142 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38255928 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37641324 |
| 122 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37324167 |
| 123 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37159792 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36521086 |
| 125 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36480217 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36043396 |
| 127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.35909359 |
| 128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35423136 |
| 129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35348168 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34619897 |
| 131 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34468378 |
| 132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33238561 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33010678 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32035002 |
| 135 | Other glycan degradation_Homo sapiens_hsa00511 | 0.30720198 |
| 136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29697068 |
| 137 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29536406 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.29300356 |
| 139 | Glioma_Homo sapiens_hsa05214 | 0.29136621 |
| 140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23815434 |
| 141 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23545746 |
| 142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22833685 |
| 143 | Phagosome_Homo sapiens_hsa04145 | 0.22551416 |

